NYU Langone Laura and Isaac Perlmutter Cancer Center Site #153 — New York, New York

NYU Langone Laura and Isaac Perlmutter Cancer Center Site #153 is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Langone Laura and Isaac Perlmutter Cancer Center Site #153 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed/Refractory Peripheral T-cell Lymphoma.

Sponsors: Taiho Oncology, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Laura and Isaac Perlmutter Cancer Center Site #153?

NYU Langone Laura and Isaac Perlmutter Cancer Center Site #153 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Laura and Isaac Perlmutter Cancer Center Site #153 conducted?

NYU Langone Laura and Isaac Perlmutter Cancer Center Site #153 has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Peripheral T-cell Lymphoma.

Is NYU Langone Laura and Isaac Perlmutter Cancer Center Site #153 accredited by Crixeo Health?

NYU Langone Laura and Isaac Perlmutter Cancer Center Site #153 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Laura and Isaac Perlmutter Cancer Center Site #153?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.